BTCY · Biotricity Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“Those conditions raise substantial doubt about its ability to continue as a going concern for a period of one year from the issuance of these condensed consolidated interim financial statements.”View the 10-Q filed Aug 19, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2023-03-12 | Al-Siddiq Waqaas |
Director, President, CEO and Chairman |
Award↑
Filing footnotes — Option (right to purchase) (Direct)
Granted pursuant to the 2016 Equity Incentive Plan, with 250,000 of the Option vested January 27, 2023, and the remaining unvested Option of 20,833 will become vested and exercisable every month thereafter starting on February 27, 2023, until the Option is 100% vested. |
Option (right to purchase)
|
1,000,000 |
| 2023-03-12 | Al-Siddiq Waqaas |
Director, President, CEO and Chairman |
Award↑
Filing footnotes — Option (right to purchase) (Direct)
Granted pursuant to the 2016 Equity Incentive Plan, with 175,000 of the Option vested January 27, 2023, and the remaining unvested Option of 175,000 will vest on January 27, 2024. |
Option (right to purchase)
|
350,000 |
| 2023-03-12 | Rosa David A |
Director, CEO and President |
Award↑
Filing footnotes — Option (right to buy) (Direct)
Granted pursuant to the 2016 Equity Incentive Plan; with immediate vesting. |
Option (right to buy)
|
75,930 |
| 2023-03-12 | Al-Siddiq Waqaas |
Director, President, CEO and Chairman |
Award↑
Filing footnotes — Option (right to purchase) (Direct)
Granted pursuant to the 2016 Equity Incentive Plan, with 175,000 of the Option vested January 27, 2023, and the remaining unvested Option of 175,000 will vest on January 27, 2024. |
Option (right to purchase)
|
350,000 |
| 2022-12-31 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
218,785 |
| 2022-09-30 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
118,282 |
| 2022-06-30 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
53,827 |
| 2022-03-31 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
37,594 |
| 2021-12-31 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |
| 2021-11-29 | Betts Norman M. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Granted in connection with the Reporting Person's service on the Company's board. Such shares were issued pursuant the Company's 2016 Equity Incentive Plan. |
Common Stock
|
54,348 |
| 2021-11-29 | Rosa David A |
Director, CEO and President |
Award↑
Filing footnotes — Common Stock (Direct)
Granted in connection with the Reporting Person's service on the Company's board. Such shares were issued pursuant the Company's 2016 Equity Incentive Plan. |
Common Stock
|
27,174 |
| 2021-10-11 | Rosa David A |
Director, CEO and President |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were issued pursuant to the Company's 2016 Equity Incentive Plan. |
Common Stock
|
3,318 |
| 2021-10-08 | Rosa David A |
Director, CEO and President |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were issued pursuant to the Company's 2016 Equity Incentive Plan. |
Common Stock
|
9,481 |
| 2021-10-07 | Rosa David A |
Director, CEO and President |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were issued pursuant to the Company's 2016 Equity Incentive Plan. |
Common Stock
|
17,228 |
| 2021-09-30 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |
| 2021-09-16 | Rosa David A |
Director, CEO and President |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were issued pursuant to the Company's 2016 Equity Incentive Plan. |
Common Stock
|
34,977 |
| 2021-09-15 | Rosa David A |
Director, CEO and President |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were issued pursuant to the Company's 2016 Equity Incentive Plan. |
Common Stock
|
6,246 |
| 2021-06-30 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |
| 2021-03-31 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |
| 2021-03-21 | Rosa David A |
Director, CEO and President |
Award↑
Filing footnotes — Option (right to buy) (Direct)
Granted pursuant to the 2016 Equity Incentive Plan; with immediate vesting. |
Option (right to buy)
|
31,106 |
| 2020-12-31 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |
| 2020-09-30 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |
| 2020-06-30 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |
| 2020-04-07 | Rosa David A |
Director, CEO and President |
Award↑
Filing footnotes — Option (right to purchase) (Direct)
Granted in connection with the Reporting Person's service on the Company's board. |
Option (right to purchase)
|
367,647 |
| 2020-04-07 | Betts Norman M. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Granted for service rendered as a member of the board of directors of the Company. |
Common Stock
|
125,000 |
| 2020-04-07 | Al-Siddiq Waqaas |
Director, President, CEO and Chairman |
Award↑
Filing footnotes — Option (right to purchase) (Direct)
The options vest quarterly over four years. |
Option (right to purchase)
|
1,400,000 |
| 2020-04-07 | Kennedy Patricia J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Granted for service rendered as a member of the board of directors of the Company. |
Common Stock
|
125,000 |
| 2020-03-31 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |
| 2020-01-24 | Ayanoglou John |
Chief Financial Officer |
Award↑
Filing footnotes — Warrants (Direct)
The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable. |
Warrants
|
50,000 |